Gladstone NOW: The Campaign Join Us on the Journey
1 - 15 of 1249 Results Clear All
The new findings have implications for developing immune therapies that target heart disease and chronic conditions in other organs.
News Release Research (Publication) Heart Failure Cardiovascular Disease Alexanian Lab Srivastava Lab
Gage has reshaped our understanding of stem cells in the adult brain with landmark discoveries that may contribute to the development of new or better therapies for neurological disorders.
Awards Institutional News News Release Ogawa Stem Cell Prize Stem Cells/iPSCs
Gladstone scientists say it’s time to think differently about how to define and treat diseases such as Alzheimer’s and multiple sclerosis.
News Release Research (Publication) Alzheimer’s Disease Dementia Multiple Sclerosis Parkinson’s Disease Neurological Disease Akassoglou Lab
Arc Institute—Gladstone investigator Isha Jain joins Arc Institute's new cohort of core investigators to drive visionary research into complex human disease. She will receive unrestricted funding to advance her research on how the body senses and responds to variations in oxygen levels and vitamins.
Grants Jain Lab
Yanilka Soto-Muñiz, a graduate student in Ken Nakamura’s lab, shares her journey from Puerto Rico to neuroscience research, highlighting her inspiration from women in science, her resilience after Hurricane Maria, and her dedication to understanding neurological diseases
Profile Neurological Disease Nakamura Lab
Scientists say it may be possible to drive the virus into “deep latency” by targeting the cellular process of transcription, by which lingering HIV cells continue to produce viral components.
News Release Research (Publication) HIV/AIDS Virology Ott Lab
San Francisco Business Times—Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, is selected as one of the Most Influential Women in Bay Area Business 2024 for her contributions as a thought leader driving innovation in AI and her mentorship of future biomedical scientists.
Awards Pollard Lab
Hear about the “Strengths-Based Model of Neurodiversity” and how it can help neurodiverse individuals be successful in finding employment and in maximizing their professional potential
Communications Diversity
Virologist Sukrit Silas hopes to turn bacteria-killing viruses into new therapies that hold promise against even the most persistent superbugs.
News Release Profile Virology
Forbes—The world woke up 17 years ago to an astounding scientific breakthrough: a team of Japanese scientists led by Shinya Yamanaka—now an investigator at Gladstone—had reprogrammed skin cells to resemble an embryonic state. In this interview, Yamanaka shares fascinating insights about the backstory of his work and the doors it is starting to open for patients today.
Gladstone Experts Yamanaka Lab Stem Cells/iPSCs
ABC7 News—The most commonly reported symptom of long COVID is brain fog, which interferes with your ability to think clearly, remember things, and focus on a task. Senior Investigator Katerina Akassoglou explains the findings from her study that shed new light on what causes brain fog and the many other brain-related symptoms of long COVID and COVID-19.
Gladstone Experts COVID-19 Akassoglou Lab
The prize will be awarded annually to a Gladstone scientist who has made breakthrough discoveries in brain research; funds will help advance scientific discoveries from the lab to the clinic.
Awards News Release Alzheimer’s Disease Neurological Disease Huang Lab Aging Human Genetics
Longtime Gladstone supporter Darlene Hines reflects on her journey of learning, growth, and giving after her husband’s passing
Donor Stories
Gladstone scientists undertake a major effort to examine the diversity of retrons, bacterial defense systems that can be leveraged for precise gene editing
News Release Research (Publication) Data Science and Biotechnology Shipman Lab
San Francisco Business Times—The world’s first CRISPR-based drug that alters the genetic code is on the market. Thousands of other therapies using gene editing or stem cell technologies are in the works and offer potential cures. But how will society pay for these life-saving drugs? In this opinion piece, Gladstone President Deepak Srivastava shares his views on a new world of medical possibilities.
Gladstone Experts Srivastava Lab
